252 related articles for article (PubMed ID: 19039140)
1. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
Chopra AR; Louet JF; Saha P; An J; Demayo F; Xu J; York B; Karpen S; Finegold M; Moore D; Chan L; Newgard CB; O'Malley BW
Science; 2008 Nov; 322(5906):1395-9. PubMed ID: 19039140
[TBL] [Abstract][Full Text] [Related]
2. The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity.
Madsen A; Bjune JI; Bjørkhaug L; Mellgren G; Sagen JV
Mol Cell Endocrinol; 2016 Jan; 419():92-101. PubMed ID: 26455881
[TBL] [Abstract][Full Text] [Related]
3. Von Gierke's disease adopts an orphan (and its partner).
Cheng A; Saltiel AR
Sci Signal; 2009 Feb; 2(58):pe8. PubMed ID: 19224896
[TBL] [Abstract][Full Text] [Related]
4. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM
J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
Waskowicz LR; Zhou J; Landau DJ; Brooks ED; Lim A; Yavarow ZA; Kudo T; Zhang H; Wu Y; Grant S; Young SP; Huat BB; Yen PM; Koeberl DD
Hum Mol Genet; 2019 Jan; 28(1):143-154. PubMed ID: 30256948
[TBL] [Abstract][Full Text] [Related]
6. Von Gierke's disease: a review.
Spahr RC
South Med J; 1976 Aug; 69(8):1022-8. PubMed ID: 183291
[No Abstract] [Full Text] [Related]
7. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.
Cho JH; Kim GY; Pan CJ; Anduaga J; Choi EJ; Mansfield BC; Chou JY
PLoS Genet; 2017 May; 13(5):e1006819. PubMed ID: 28558013
[TBL] [Abstract][Full Text] [Related]
8. Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Zingone A; Hiraiwa H; Pan CJ; Lin B; Chen H; Ward JM; Chou JY
J Biol Chem; 2000 Jan; 275(2):828-32. PubMed ID: 10625614
[TBL] [Abstract][Full Text] [Related]
9. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
Kim GY; Lee YM; Cho JH; Pan CJ; Jun HS; Springer DA; Mansfield BC; Chou JY
Hum Mol Genet; 2015 Sep; 24(18):5115-25. PubMed ID: 26089201
[TBL] [Abstract][Full Text] [Related]
10. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse.
Lei KJ; Chen H; Pan CJ; Ward JM; Mosinger B; Lee EJ; Westphal H; Mansfield BC; Chou JY
Nat Genet; 1996 Jun; 13(2):203-9. PubMed ID: 8640227
[TBL] [Abstract][Full Text] [Related]
11. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
Kaneko K; Soty M; Zitoun C; Duchampt A; Silva M; Philippe E; Gautier-Stein A; Rajas F; Mithieux G
Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Chou JY; Zingone A; Pan CJ
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S56-61. PubMed ID: 12373573
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase.
Shieh JJ; Terzioglu M; Hiraiwa H; Marsh J; Pan CJ; Chen LY; Chou JY
J Biol Chem; 2002 Feb; 277(7):5047-53. PubMed ID: 11739393
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.
Koeberl DD; Sun B; Bird A; Chen YT; Oka K; Chan L
Mol Ther; 2007 Jul; 15(7):1253-8. PubMed ID: 17505475
[TBL] [Abstract][Full Text] [Related]
15. Two different anesthetic managements of a patient with von Gierke's disease.
Huang IR; Jean WH; Lu CW; Wu CC; Lin TY; Chuang YH; Sun WZ
Acta Anaesthesiol Taiwan; 2006 Mar; 44(1):51-3. PubMed ID: 16623410
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Wang Y; Oeser JK; Yang C; Sarkar S; Hackl SI; Hasty AH; McGuinness OP; Paradee W; Hutton JC; Powell DR; O'Brien RM
J Biol Chem; 2006 Dec; 281(52):39982-9. PubMed ID: 17023421
[TBL] [Abstract][Full Text] [Related]
18. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Sun MS; Pan CJ; Shieh JJ; Ghosh A; Chen LY; Mansfield BC; Ward JM; Byrne BJ; Chou JY
Hum Mol Genet; 2002 Sep; 11(18):2155-64. PubMed ID: 12189168
[TBL] [Abstract][Full Text] [Related]
19. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
Roseman DS; Khan T; Rajas F; Jun LS; Asrani KH; Isaacs C; Farelli JD; Subramanian RR
Mol Ther; 2018 Mar; 26(3):814-821. PubMed ID: 29428299
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of thrombocytic glucose-6-phosphatase in patients with von Gierke's disease and its heterozygotes.
Soyama K; Shimada N; Kusunoki T; Nakamura T
Clin Chim Acta; 1973 Mar; 44(3):327-31. PubMed ID: 4348485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
